WeightWatchers buys telehealth provider Sequence

WeightWatchers’ stock soared Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence.

Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under the brand names including Ozempic, Wegovy and Trulicity. The drugs all work by the same mechanism: They trigger the release of insulin, block sugar production in the liver and…